Photobiomodulation and the Intralesional Administration of Corticoid in the Keloid Surgery.

• Status: Enrolling by invitation
• Trial end date: 2022-10-01
• Target enrollment: 0
• Participant gender: All

Summary

A randomized, controlled, double-blind, clinical trial will be conducted to study the evaluate the effect of blue light combined with corticoid treatment in the preoperative and postoperative period of keloid removal surgery.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Nove de Julho
• Treatments: Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• Age: 18 to 65 years;

• Fitzpatrick skin phototype I-VI;

• Keloid with no type of previous treatment;

• Recurring keloid after surgical excision;

• Recurring keloid after use of other therapies and at least three months without treatment.

Exclusion Criteria:

• Keloid in treatment;

• Pregnant and lactating women;

• Keloid with primary synthesis of the skin and no possibility of excision.

• Contraindications for undergoing surgery (e.g.: coagulopathies, diabetes myellitus, drug allergies);

• Contraindications for the use of corticosteroids;

• All types of Collagenosis.